US2004042990A1PendingUtilityA1
Composition containing oxidation-sensitive hydrophilic active principle and maleic anhydride copolymer, and use thereof
Est. expiryJun 20, 2022(expired)· nominal 20-yr term from priority
Inventors:Bruno Biatry
A61P 39/06A61P 43/00A61K 8/347A61K 8/8164A61Q 17/00A61K 2800/412A61K 8/676A61Q 19/02A61K 8/11A61P 17/00A61Q 5/08A61P 17/16A61Q 19/007A61Q 19/08A61Q 19/00A61K 8/8182A61K 2800/522A61K 2800/52A61Q 17/04A61K 8/4973
54
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to the use of a composition, especially for preventing and/or treating cutaneous signs of intrinsic ageing, the composition containing at least one oxidation-sensitive hydrophilic active principle selected from the group consisting of ascorbic acid and its compounds and at least one maleic anhydride copolymer.
Claims
exact text as granted — not AI-modified1 . A method for preventing and/or treating cutaneous signs of intrinsic ageing, comprising applying to skin a composition comprising at least one oxidation-sensitive hydrophilic active principle selected from the group consisting of ascorbic acid and its compounds and at least one maleic anhydride copolymer comprising one or more maleic anhydride comonomer units and one or more comonomer units selected from the group consisting of vinyl acetate, vinyl alcohol, vinylpyrrolidone, olefins comprising from 2 to 20 carbon atoms, and styrene, in a physiologically acceptable medium comprising an aqueous phase.
2 . The method according to claim 1 , wherein said method is a method of treating cutaneous signs of intrinsic ageing comprising applying said composition to skin in need thereof.
3 . The method according to claim 1 , wherein said method is a method of preventing cutaneous signs of intrinsic ageing comprising applying said composition to skin in need thereof.
4 . The method according to claim 1 , wherein the hydrophilic active principle is selected from the group consisting of 5,6-di-O-dimethylsilylascorbate, the dl-α-tocopheryl dl-ascorbyl phosphate potassium salt of ascorbic acid, magnesium ascorbyl phosphate, sodium ascorbyl phosphate and ascorbyl glucoside.
5 . The method according to claim 1 , wherein the oxidation-sensitive hydrophilic active principle is ascorbic acid.
6 . The method according to claim 1 , wherein the maleic anhydride units of the copolymer are in the hydrolysed form and in the form of alkaline salts.
7 . The method according to claim 1 , wherein the oxidation-sensitive active principle and the copolymer are both in the aqueous phase.
8 . The method according to claim 1 , wherein the copolymer has a molar fraction of maleic anhydride units of between 0.1 and 1.
9 . The method according to claim 8 , wherein the copolymer has a molar fraction of maleic anhydride units of between 0.4 and 0.9.
10 . The method according to claim 1 , wherein the copolymer is a copolymer of styrene and of maleic anhydride in a 50/50 ratio.
11 . The method according to claim 1 , wherein the copolymer is a copolymer of styrene and of maleic anhydride in a 50/50 ratio in the form of an ammonium or sodium salt.
12 . The method according to claim 1 , wherein the molar ratio of the maleic anhydride unit equivalent to the oxidation-sensitive hydrophilic active principle varies between 0.005 and 10.
13 . The method according to claim 1 , wherein the molar ratio of the maleic anhydride unit equivalent to the oxidation-sensitive hydrophilic active principle varies between 0.01 and 1.
14 . The method according to claim 1 , wherein the copolymer is present at a concentration of between 0.1 and 40% by weight of the aqueous phase.
15 . The method according to claim 1 , wherein the copolymer is present at a concentration of between 0.1 and 10% by weight of the aqueous phase.
16 . The method according to claim 1 , wherein the composition further comprises at least one non-ascorboc acid active principle which stimulates dermal macromolecules or which prevents their decomposition and/or an agent which stimulates the proliferation of fibroblasts or keratinocytes and/or the differentiation of keratinocytes.
17 . A method for preventing and/or treating cutaneous signs of intrinsic ageing, comprising applying to skin or mucous membranes a composition comprising at least one oxidation-sensitive hydrophilic active principle selected from the group consisting of ascorbic acid and its compounds and at least one maleic anhydride copolymer comprising one or more maleic anhydride comonomer units and one or more comonomer units selected from the group consisting of vinyl acetate, vinyl alcohol, vinylpyrrolidone, olefins comprising from 2 to 20 carbon atoms, and styrene, in a physiologically acceptable medium comprising an aqueous phase.Join the waitlist — get patent alerts
Track US2004042990A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.